Ayala Pharmaceuticals Inc

+0.29 (+4.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)94.62M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.67 Million
Adjusted EPS-$0.57
See more estimates
10-Day MA$7.06
50-Day MA$9.02
200-Day MA$10.52
See more pivots

Ayala Pharmaceuticals Inc Stock, NASDAQ:AYLA

Oppenheimer 4, Suite 5100, Rehovot, Tel Aviv 7670104
United States of America
Phone: +972.8.373.1541
Number of Employees: 34


Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel.